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There are currently different techniques, such as CGH arrays, to study genetic variations in patients. CGH arrays analyze gains
and losses in different regions in the chromosome. Regions with gains or losses in pathologies are important for selecting relevant
genes or CNVs (copy-number variations) associated with the variations detected within chromosomes. Information corresponding
to mutations, genes, proteins, variations, CNVs, and diseases can be found in different databases and it would be of interest to
incorporate information of different sources to extract relevant information. This work proposes a multiagent system to manage
the information of aCGH arrays, with the aim of providing an intuitive and extensible system to analyze and interpret the results.
The agent roles integrate statistical techniques to select relevant variations and visualization techniques for the interpretation of the
final results and to extract relevant information from different sources of information by applying a CBR system.
1. Introduction
There are various techniques for performing studies on
genetic variations in patients, including expression arrays
[1, 2], CGH (comparative genomic hybridization) arrays
[3], and studies at the genetic sequence level. CGH arrays
allow comparing the DNA of a patient with a control DNA
and using this information to detect mutations [4, 5] based
on gains, losses, and amplifications [6]. Another kind of
microarrays is the expression arrays, which determine the
expression of different genes with probes. CGH are used
to detect regions in the chromosomes with variations in
certain pathologies. This information is taken into account
for sequencing these regions through the use of expression
arrays and sequencers [7]. In these studies, the users have
to work with a vast amount of information, which implies
the development of systems oriented to improve the analysis
of the data and to automatically extract information using
databases [8]. For this reason, it is necessary to identify the
exact location of those interesting genes inCGHarrays before
carrying out the sequencing.
There are currently various tools that provide a visual
analysis of the information of aCGH. These tools typically
represent the information but the interaction with the infor-
mation is complex. The visual analysis is used to represent
additional information about relevant regions. Some of these
tools can be found in works [9–14]. A visual analysis of these
data is normally performed manually [14, 15], which requires
the participation of experts to select the relevant information.
However, these tools lack usability and require the use of tech-
niques that facilitate the automatic analysis and extraction
of information from different sources. For this reason, it is
necessary to incorporate a process that helps determine the
interesting genes [16], proteins, and relationships to diseases
that must be analyzed and understood in a simpler way.
The distributed analysis of CGH data is performed by
different laboratory personnel, from hybridating the chips to
extracting the relevant variations and information associated
with the chips. This work shows a multiagent system specif-
ically designed to analyze CGH data [17]. The functionality
of the multiagent system is divided into layers and roles
to carry out the analysis of CGH arrays. The analysis is
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usually composed of several stages. The first stage is the
segmentation process [18], which implements the subsequent
analysis of the data and is important to be able to represent
a visualization of the data. The remaining stages depend
on the analysis to be performed and include clustering,
classification, visualization, or extraction of information from
databases. The proposed multiagent system manages the
analysis and the automatic interpretation of the data. The
system can select the relevant genes and transcripts for
the prior classification of pathologies. The information of
the identified genes is obtained from public databases. The
information management system is based on the CBR (case-
based reasoning) model [19, 20] to detect the mutations,
genes, proteins, and diseases. Finally, visualization assists the
user in reviewing the results.
This paper is organized as follows. Section 2 describes
the state of the art in CGH arrays, Section 3 describes the
proposal, and Section 4 presents the results and conclusions.
2. CGH Arrays
Array-based comparative genomic hybridization (aCGH) is a
kind ofmicroarray that analyzes areas of the genome to detect
gains or losses. Whereas traditional high-resolution chromo-
some analysis detects chromosome structure alterations at
a resolution of 5 megabases (Mb) or greater, aCGH detects
gains or losses of DNA that cannot be seen by traditional
karyotyping and may sometimes be only thousands of base
pairs in size [21]. aCGHhas emerged as a powerful diagnostic
technique for high resolution analysis of the human genome.
It is a specific, sensitive, and rapid technique that can
detect genomic arrangements and copy-number changes. A
variety of array CGH platforms are currently available, both
commercially and in academic institutions. The choice of
platformmay depend on the type of data sought; however, the
price, reproducibility, and standardization are crucial factors
that need to be considered [22].
CGH arrays incorporate segments of DNA that are
defined with genome databases. The clones are predomi-
nantly selected to target areas of the human genome that,
when deleted or duplicated, are known or highly suspected to
cause well-characterized genetic defects. Microarray printers
attach the clones to a glass slide in an organized way
to form a microarray. A typical microarray slide contains
thousands of different clones representing targeted areas of
the genome. Fluorescently labeledDNA fromboth the patient
and a known normal human control are applied to the slide
and compete to attach or hybridize to their corresponding
DNA segments. The fluorescent signals are analyzed and,
depending of the values obtained, it is possible to detect areas
with unequal hybridization of a patient versus control DNA.
The first whole genome microarray contains 2,400 large-
insert genomic clones, primarily bacterial artificial chro-
mosomes (BACs). With the total human genome covering
approximately 3,000Mb, the resolution of this array is on
average close to 1Mb, about one order of magnitude higher
than that obtainedwith classical CGH[23]. For a full coverage
resolution array, approximately 30,000 BACs have been
arrayed [24], increasing the resolution with another order of
magnitude. However, producing such large numbers of BACs
for array CGH is expensive and time-consuming and, due
to the large size of the BACs, the limits of BAC array CGH
resolution have been reached. These problems can be over-
comewhen oligonucleotides are used as targets inmicroarray
experiments. Oligonucleotides allow a sheer infinite reso-
lution, great flexibility and are cost-effective [3]. Moreover,
oligonucleotides allow for the generation of microarrays for
any organism for which the genome has been sequenced.
Attempts have been undertaken to increase the resolution
of BAC arrays in other ways, but CGH cannot compete
with the flexibility and versatility of oligonucleotides. Finally,
oligonucleotide arrays are being used, designed, and accepted
for expression profiling and are thus widely available [25].
In conclusion, BAC arrays (array-based comparative
genomic hybridization) have proved to be successful for the
detection of submicroscopic DNA copy-number variations.
Technological improvements to achieve a higher resolution
have resulted in the generation of additional microarray
platforms encompassing larger numbers of shorter DNA
targets (oligonucleotides). Currently, both types (BAC and
oligo arrays) have advantages and disadvantages. The BAC
clone targets have been mapped to the human reference
sequence produced by the International Human Genome
Sequencing Consortium, allowing easy access to information
in the related genomic databases. However, BACs, which are
usually 100–200 kb,maymiss alterations smaller than the size
of a clone but are less likely to detect alterations of unclear
clinical significance. For this reason, they are unable to
distinguish deletions/amplification less than approximately
85 kb.
Oligonucleotides, which aremuch smaller probes, usually
25–60 bp, may detect small alterations that would not be
seen using a BAC microarray, but oligonucleotide arrays are
more likely to detect small alterations of unclear clinical
significance.
3. Multiagent System
The multiagent system is composed of three layers: anal-
ysis, information management, and visualization. Figure 1
shows the multiagent system architecture and the layers
it comprises. The analysis layer performs the microarray
analysis. It includes several algorithms that can be applied
to the specific case study taken into consideration. The
information management layer generates a local database
using the information of several sources. The visualization
layer manages the information and the algorithms. It displays
the information and the results obtained after applying the
existing algorithms at the analysis layer.
The analysis layer contains the DF (Directory Facilitator)
agent, which registers the different types of agents that
are contained in that layer and the services they provide.
Each agent provides a set of services to perform certain
functionalities that can be requested by other agents. This
separation allows the inclusion of new functionalities in the
application by modifying the services provided by the agents
at the analysis layer.
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Figure 1: Multiagent system architecture.
The information management layer contains an agent for
each external source of information. Each agent is responsible
for retrieving the information requested by the Manager
agent, which compiles the information from the agents and
generates a local database.
The agents at the visualization layer consult with the DF
to obtain the services provided for each existing process.
Additionally, these agents can contact the Manager in the
information management layer to obtain relevant informa-
tion that appears during the analysis.
The following subsections describe each one of the layers
adapted to the case study for CGH arrays.
3.1. Analysis Layer. The agents in these layers perform
different tasks for processing information, specifically the
processing tasks that will be used in the case study and
the chips. It is necessary to take into account that the
algorithms can be adapted to each case study. In the particular
case presented in this work, this layer contains agents for
normalization and segmentation, knowledge extraction, and
clustering.
3.1.1. Normalization and Segmentation. During this process,
the data are preprocessed in order to segment them and
reduce noise. This state is important to represent the infor-
mation and extract relevant regions. While there are many
algorithms capable of carrying out the preprocessing, the
package snapCGH [18] R Server was used in this tool to
normalize and segment the data. The package incorporates
algorithms as aCGH, DNACopy, and GLAD [26, 27]. It is
important to use algorithms in order to compare the different
results; additionally, this package is widely used.
In order to compare all of the arrays simultaneously, the
value is readjusted for all data that were previously processed
by NimbleGen, which normalizes and segments each of the
arrays. The data are then scaled according to the mad1dr
(median absolute deviation) provided by NimbleGen. The
process is defined according to the function
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where 𝑥 represents the value of the segment,𝑚 is the value of
the mad1dr for the given array, tl is the loss threshold, and tg
is the gain threshold.
3.1.2. Knowledge Extraction and Classifiers. There are cur-
rently several kinds of classifiers based on different technolo-
gies: decision rules and decision trees RIPPER [28], One-R
[29],M5 [30], J48 [31], CART [1] (classification and regression
trees), probabilistic models naive Bayes [32], fuzzymodels K-
NN (K-nearest neighbors) [33], neural networks [34], and so
forth. Some of these classifiers can be used to extract relevant
information in order to obtain attributes, and this process can
be carried out by traditional statistical techniques to compare
values using the parametric or not parametric test ANOVA
[35], Kruskal-Wallis [36], and Mann-Whitney 𝑈 test [37] or
testing to compare the frequencies as parametric Chi squared
[38] or Fisher’s exact test. The gain functions are a particular
case of the techniques used in decision trees and decision
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Input: CGHArrays, Groups
Output: RelevantSegments
𝑅𝑒𝑙𝑒V𝑎𝑛𝑡𝑆𝑒𝑔𝑚𝑒𝑛𝑡𝑠 ← 0
foreach 𝑠𝑒𝑔𝑚𝑒𝑛𝑡 ∈ 𝐶𝐺𝐻𝐴𝑟𝑟𝑎𝑦𝑠/𝐺𝑟𝑜𝑢𝑝𝑠$𝑝𝑎𝑡ℎ𝑜𝑙𝑜𝑔𝑖𝑒 do
𝑐𝑡 ← 𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝐶𝑜𝑛𝑡𝑖𝑛𝑔𝑒𝑛𝑐𝑦𝑇𝑎𝑏𝑙𝑒(𝑠𝑒𝑔𝑚𝑒𝑛𝑡, 𝐺𝑟𝑜𝑢𝑝𝑠, 𝐶𝐺𝐻𝐴𝑟𝑟𝑎𝑦);
// Chi Squared test
if 80% of the data from a ct > 5 then
𝜒2 ←∑
𝑖,𝑗
𝑓
𝑖𝑗
− 𝑓
𝑖⋅
∗ 𝑓
⋅𝑗
/𝑓
⋅⋅
𝑓
𝑖⋅
∗ 𝑓
⋅𝑗
/𝑓
⋅⋅
;
𝑑𝑓 ← (𝑟𝑜𝑤(ct) − 1)(𝑐𝑜𝑙(ct) − 1);
𝑃-value← 𝑐𝑎𝑙𝑐𝑢𝑙𝑎𝑡𝑒𝑃𝑉𝑎𝑙𝑢𝑒(𝜒2, 𝑑𝑓);
end
// Fisher’s Exact test
else
𝑃-value←
(
𝑓
11
+ 𝑓
21
𝑓
11
)(
𝑓
12
+ 𝑓
22
𝑓
12
)(
𝑓
13
+ 𝑓
23
𝑓
13
)
(
𝑓
⋅⋅
𝑓
11
+ 𝑓
12
+𝑓
13
)
;
end
// H0: pathology and the segments are independents
if 𝑃-value < 0.05 then
𝑅𝑒𝑙𝑒V𝑎𝑛𝑡𝑆𝑒𝑔𝑚𝑒𝑛𝑡𝑠 ← 𝑅𝑒𝑙𝑒V𝑎𝑛𝑡𝑆𝑒𝑔𝑚𝑒𝑛𝑡𝑠 ∪ 𝑠𝑒𝑔𝑚𝑒𝑛𝑡;
end
end
Algorithm 1: Automatic selection of segments.
rules for selecting the attributes, which is why they are not
considered separately.
For this particular system, the decision trees were chosen
to select the main genes of the most important pathologies,
specifically the J48 [31] in its implementation for Weka [39].
However, if the system needs a generic selection, gain func-
tions or statistical test is chosen (specifically Chi squared).
Chi squared test [38] was selected because it can work
with qualitative and nominal variables and it provides an
easy way to select relevant regions depending on a 𝑃 value.
Fisher’s exact test [40, 41] is applied, which is the recom-
mended method when the sample size is small, and it is not
possible to ensure that 80% of the expected frequency from a
contingency table has a value greater than 5. Table 1 displays
the information used in the contingency tables to carry out
the statistical tests.
The segments that were considered most relevant for
each of the CGH arrays were selected for each pathology.
Algorithm 1 displays the selection algorithm for the relevant
segments used for the set of arrays and for the individuals
with or without a particular pathology, as identified by the
groups variable. The algorithm was applied repeatedly for
each existing pathology.
3.1.3. Cluster. There is a wide range of possibilities in data
mining. Some of these techniques are artificial neural net-
works such as SOM [42] (self-organizing map), GNG [43]
(growing neural gas) resulting from the union of techniques
CHL [44] (competitive Hebbian learning) and NG [45]
(neural gas), and GCS [43] (growing cell structure).There are
Table 1: Contingency table.
Gain Normal Loss Total
Pathology 𝑓
11
𝑓
12
𝑓
13
𝑓
1⋅
= total
pathology
Not
pathology 𝑓21 𝑓22 𝑓23
𝑓
2⋅
= total not
pathology
Total 𝑓⋅1 = totalgains
𝑓
⋅2
= total
normal
𝑓
⋅3
= total
losses 𝑓⋅⋅ = total
other techniques with fewer computational costs that provide
efficient results. Among them we can find the dendrogram
and the PAMmethod [46] (partitioning around medoids). A
dendrogram [47] is an ascendant hierarchical method with
a graphical representation that facilitates the interpretation
of results and allows an easy way to establish groups without
prior establishment. The PAMmethod requires selecting the
number of clusters previous to its execution.
Dendrograms are hierarchical methods that initially
define conglomerates for each available case. The algorithm
is modified so that each coordinate stores the values −1, 0,
and 1 to indicate that the segment has a loss, no variation,
or a gain, respectively. At each stage, the method joins the
two conglomerates with the least distance and then calculates
the distance of the other conglomerate to this new one.
The new distances are updated in the matrix of distances.
The process finishes when there is only one conglomerate
remaining (agglomerativemethod).The distancemetric used
in this paper was the average linkage, a metric that calculates
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Input: CGHArrays, thresholdLost, thresholdGain
Output: RootNodeTree
𝐶𝐻𝐺𝐴𝑟𝑟𝑎𝑦𝑠𝑁 ← 𝐶𝐺𝐻𝐴𝑟𝑟𝑎𝑦𝑠
foreach 𝑐ℎ𝑔𝐴𝑟𝑟𝑎𝑦 ∈ 𝐶𝐺𝐻𝐴𝑟𝑟𝑎𝑦𝑠𝑁 do
foreach V𝑎𝑙𝑢𝑒 ∈ 𝑐𝑔ℎ𝐴𝑟𝑟𝑎𝑦 do
if V𝑎𝑙𝑢𝑒 < 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑𝐿𝑜𝑠𝑡 then V𝑎𝑙𝑢𝑒 ← −1;
else if V𝑎𝑙𝑢𝑒 > 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑𝐺𝑎𝑖𝑛 then V𝑎𝑙𝑢𝑒 ← 1;
else V𝑎𝑙𝑢𝑒 ← 0
end
end
listNodes← calculateLeafNodes(CHGArraysN);
While listNodes.size() > 1 do
distances← calculateDistances(listNodes);
[node𝑖, node𝑗] ←minDistance(distances);
// Calculate a new node with the median of nodei and nodej
treeNode← fusion(node𝑖, node𝑗);
listNodes.remove({node𝑖, node𝑗});
listNodes.add(treeNode);
end
Algorithm 2: Dendrogram algorithm.
the average distance of each pair of nodes for the two
groups and, based on these distances, merges the groups.
The metric is known as the unweighted pair group method
using arithmetic averages (UPGMA) [48].This type of cluster
was selected since it allows the grouping process to be easily
reviewed by visualizing the results. Dendrogram algorithm is
described in Algorithm 2.
3.2. Information Management. The information manage-
ment layer includes a different agent for each available
source of information that is managed by the Manager
agent. The specific agents used are UCSC, Ensembl, CNVs
(copy-number variations), and annotation [49].These agents
download existing information from the databases managed
by the Manager agent to generate the local database. They
specifically download information related to genes, proteins,
pathologies, genomic variants, and CNV. This information
is compiled by the Manager agent, who is responsible for
generating a local database that will be used as a source of
information. In addition to the information retrieved from
the database, the system stores the annotations created by the
system experts for future data analysis.
When the information in the GUI database requires
updating, the Manager agent orders the agents to download
the updated information from the remotewebsites. Using this
information, the agent then stores the data in the system’s
local database in order to improve performance. There are
different local databases for the different versions of HG that
are being used.The data model used for each of the databases
follows the class model shown in Figure 2.
Although the information from the tables is downloaded
from UCSC, the data model does not follow the same
diagram; the information stored in the tables does, however,
correspond to the information that can be found for the
equivalent tables in UCSC:
(i) DGV: database of genomic variants,
(ii) annotation: comments that are inserted into regions
of the chromosomes,
(iii) chromosome: table with information for the chromo-
somes which only stores the chromosome identifier,
(iv) CNV: table that stores information used to represent
the copy-number variations,
(v) KnownGene: table with information about the genes,
(vi) KeggPathway: KEGG pathway cross-reference,
(vii) KgXref: linking together a known gene ID and a gene
alias, used to extract the information commonly used
to identify genes,
(viii) Hgnc: a cross-reference table between HUGO Gene
Nomenclature Committee (HGNC) IDs and other
database IDs,
(ix) SpDisease: a cross-reference table between Swiss-Prot
IDs and disease description.
The advantage is that all of the information is generated
in a single database and stored locally, which improves
performance; additionally, new tables such as CNV can
be added, or further annotations can be provided to the
database.
3.3. Visualization. aCGH is a technique to detect variations
in patients who have different mutations in chromosomal
regions. Usually the variations have already been catalogued,
which is why the existing information can be used to
catalogue and evaluate the mutation. In this case study, the
cases were defined according to the segments in which the
chromosomic regions have been fragmented. Therefore, in a
CBR system [50], the retrieval and selection phase is adapted
to get the most suitable information that solves the problem.
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Figure 2: Class diagram with the information stored in the databases.
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Figure 3: Chromosome 19 losses in red and gains in green.
Cases involving stored memory correspond to the infor-
mation for the region and the information associated with
the region.There are cases associated with genes, pathologies,
CNVs, annotations, variants, and duplications.The algorithm
selected for the retrieval of cases should be able to search
the case base and select the genes, the known transcripts
associated with the region, the variations to gains or losses,
and so forth in the regions. The retrieved genes and tran-
scripts are shown with each of the segments to validate the
obtained results using the analysis techniques. The revision
phase is carried out by an expert, and finally the retained
phase allows storing the information considered relevant.The
analysis process followed by the system is shown in Figure 3.
During the retrieval stage, the information previously
stored by the Manager agent is retrieved from databases such
as UCSC or Ensembl.The retrieved information is that which
is considered the most relevant and is organized in order
to generate local databases, which are completed with other
existing information, such as that originating from the copy-
number variations.
The stored information is reused during the reuse phase
in order to generate the reports, which are provided to
the end user, on the analysis of the regions that stand out
during a visual analysis or automatic analysis of the data.
Part of this information is also used to draw regions and
nonrelevant mutations, which helps the subsequent revision
of the selected segments as relevant.
The revision phase is carried out by an expert who
determines the relevance of the selected regions according to
the variations and the information retrieved from the reports.
The expert also inputs any annotations considered relevant
regarding the detected variations, which are stored during the
learning phase for future analysis of new patients. Moreover,
the revision is facilitated by representing information such
as the CNVs and the annotations, which eliminates the
variations that are not considered relevant.
BioMed Research International 7
Figure 4: Automatic selection of segments.
4. Results
The multiagent system designed in this work was applied to
the study of CGH arrays. A functionality was developed to
study the different types of arrays. The system was applied
on three different kinds of CGH arrays: BAC aCGH, oligo
aCGH, and SNP CGH. Although these arrays are similar, the
information provided by each differs considerably because
the segments are defined in different ways.
The first step in the analysis of CGH arrays is the
segmentation and normalization process; Table 2 shows the
information obtained from the BAC arrays after this step.
In this kind of array, all patients are represented by the
same segments, shown as rows in the image. Each segment
contains information about the chromosome, initial position
andfinal position. For each region,we have a value V
𝑖𝑗
with the
information of gains and losses for the segment 𝑖 and patient
𝑗; these values represent gains or losses if they are greater or
lower than a threshold.
An analysis using oligo aCGH shows that the available
information is different.The information from these arrays is
shown in Table 3.The values V
𝑖𝑗
represent gains and losses for
segment 𝑖 and patient 𝑗. Each patient has a different number
of segments, whichmight not have the same initial value; this
means that the initial or final value of segment 𝑖 and patient 𝑗
can be different from segment 𝑖 and patient 𝑘.
Finally, the system includes databases since the system
extracts the information regarding genes, transcripts, CNV,
and local annotations.
Figure 4 shows the information from the BAC arrays
cases, which includes 38 cases with 5 different pathologies.
Only the information corresponding to chromosome 12 is
shown. The green lines show gains regions in the chro-
mosome, while red lines show losses. Therefore, the figure
shows that the green patients have gains while the remainder
presents few variations.Themost relevant segments are auto-
matically highlighted as bright segments with the application
of the hypothesis contrast Chi squared test. This technique
allows the selection of the regions of interest.
Once the data are represented, a CBR reasoning cycle is
performed. During the retrieval phase, information regard-
ing the catalogued genes and transcripts is recovered from the
Table 2: BAC aCGH segmented and normalized.
Patient 1 Patient 2 Patient 3 ⋅ ⋅ ⋅ Patient 𝑛
Segment 1
(chromosome-init-
end)
𝑉
11
𝑉
12
𝑉
13
⋅ ⋅ ⋅ 𝑉
1𝑛
Segment 2
(chromosome-init-
end)
𝑉
21
𝑉
22
𝑉
23
⋅ ⋅ ⋅ 𝑉
2𝑛
...
...
...
...
...
...
Segment𝑚
(chromosome-init-
end)
𝑉
𝑚1
𝑉
𝑚2
𝑉
𝑚3
⋅ ⋅ ⋅ 𝑉
𝑚𝑛
database. During the reuse phase, these genes are evaluated
and valued according to the hypothesis contrast described in
Section 3. After selecting the segments, their relevance can
be observed. Figure 5 shows the information from the genes
that were recovered from the database and considered to be
relevant.
In addition to visualizing the information for each of
the different segments, it is also possible to generate reports
automatically. These reports make it possible to quickly visu-
alize potentially relevant information from the regions about
proteins, genes, and diseases. Figure 6 displays information
related to proteins, genes, anddiseases.The systemalsomakes
it possible to generate reports on variants, duplications, or
CNVs.
The system provides several visualizations to support the
revision of the information by an expert. The system allows
for information about the previously analyzed regions to be
included, which makes it possible to eliminate regions that
were not previously considered relevant. Additionally, the
system can include representations of different variations,
whichmakes it possible to eliminate regionswhosemutations
have already been catalogued as not relevant. This helps
the visual analysis and selection of relevant regions. The
pink area highlighted in Figure 7 represents the regions
presented by CNV; there is a gains area highlighted in
green which corresponds to a CNV and should not be
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Table 3: Oligo aCGH segmented and normalized.
Patient 1 Patient 2 ⋅ ⋅ ⋅ Patient 𝑛
Segment 11
(chromosome-init-end) 𝑉11
Segment 12
(chromosome-init-end) 𝑉12 ⋅ ⋅ ⋅
Segment 1𝑛
(chromosome-init-end) 𝑉1𝑛
Segment 21
(chromosome-init-end) 𝑉21
Segment 22
(chromosome-init-end) 𝑉22 ⋅ ⋅ ⋅
Segment 2𝑛
(chromosome-init-end) 𝑉2𝑛
...
... ...
...
... ...
...
Segment𝑚1
(chromosome-init-end) 𝑉𝑚1
Segment𝑚2
(chromosome-init-end) 𝑉𝑚2 ⋅ ⋅ ⋅
Segment𝑚𝑛
(chromosome-init-end) 𝑉𝑚𝑛
...
...
... ...
...
Segment 𝑘2
(chromosome-init-end) 𝑉𝑘2 ⋅ ⋅ ⋅
Segment 𝑙𝑛
(chromosome-init-end) 𝑉𝑙𝑛
Figure 5: Automatic selection of segments and genes.
Figure 6: Automatic report with information from the highlighted segments.
taken into consideration in the analysis. The information
from the annotations inserted by laboratory personnel is
likewise shown, with the color varying according to the
user’s selection. Another variation with respect to Figure 4 is
that the data are represented as an accumulated amount as
opposed to per individual patient, which allows the regions
of gains or losses to be easily observed. The regions that were
automatically selected by the analysis tests can bemodified by
using a mouse to mark the segments with a selection square
or by dragging the triangles located in the lower part of the
chromosome.
If there are any doubts, it is possible to consult the UCSC
website to determine the relevance of a specific segment;
to see the accumulated view, simply click on the segment
and then select OK for the UCSC option for either the
complete segment of the patient or the minimum region
into which each segment has been resegmented. Figure 8
shows the window from the UCSC site and the dialogue
box that appears after clicking on a particular segment.
This information is useful to analyze the relevance of the
regions by taking into consideration the different knowledge
extraction techniques applied.
Figure 9 shows a representation in parallel coordinates
and a bar graph. In the bar graph, one bar represents each
individual and is divided into different segments with an
amplitude proportional to the width of the segment. The
color of the top rectangle represents the type of pathology
the patient has. In parallel coordinates, each line is associated
BioMed Research International 9
Figure 7: Accumulated view of chromosome 5 together with information from the CNVs.
Figure 8: Information from UCSC for the selected segment.
Figure 9: Clustering review with a bar graph and parallel coordinates.
with a patient and the color represents the pathology type.
Each coordinate represents a segment. If we select the patients
from the green category in the stacked bars, we can see
how the other bars are deactivated, which indicates that
the patients have variations within different ranges; only
the patients with variations within the range of the selected
patients remain active, which makes it easy to see other
similar patients. In the parallel coordinates, the values of
each coordinate are adjusted to the maximum and minimum
extremes for the selected individuals. The lines for each
selected individual are highlighted while those not within the
range of maximum and minimum values as established for
each coordinate are marked in gray.
In the case of Figure 9, the number of segments selected
was very high, which explains the appearance of so many
coordinates. Having selected fewer, the number of coordi-
nates would be lower, making it easier to see the range of
variation for each of the coordinates.
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Figure 10: Grouped individuals according to the highlighted segments for each chromosome.
If there are no groups, the system can also create a cluster
of individuals which can then be revised by selecting the
individuals with a mouse and modifying the cluster to which
they belong. Clusters can be made only according to the
information from the chromosomes that can be seen on the
screen and only based on the highlighted segments, which
makes it possible to create a group according to the infor-
mation considered relevant. Figure 10 shows a cluster created
from chromosomes 5 and 11 using all of the information
from chromosome 11 and the highlighted information from
chromosome 5.Once the dendrogramwas created, the cluster
was manually corrected by selecting individuals one by one.
5. Conclusions
Visualization also makes it possible to carry out tasks, such as
drag and drop, for each visualization, to export information
in image format, to select thresholds, chromosomes to visual-
ize, categories, individuals, to zoom, or to import Affymetrix
(multiple tsv files) and NimbleGen (multiple txt files) data.
The multiagent system can add agents that specialize in
specific case studies and allows the reuse of functionalities
for specific layers. Furthermore, the independence of the
different modules in this kind of system allows for the easy
inclusion of new techniques. This case study used the aCGH
data analysis to facilitate the addition and/or modification of
existing techniques.The system provides easy access to infor-
mation of several databases, improving the visual analysis
of the information and proving relevant information of the
selected regions of the chromosome.The system uses CBR to
automatically select the genes that characterize pathologies.
This CBRmanages all the information of the databases and it
allows the incorporation of new information that can be used
in future analyses.
Finally, the different visualization can easily manage the
data, thus improving the efficiency of the experts in the
selection of relevant regions, its validation, and the access to
information associated with these regions.
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